Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.40 |
| ▸ | ACE | P12821 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7140993 | 0.98 | CYP2D6 (0.42) | HSD17B10CYP2D6CYP2C19POLBCYP2C9 | |
| SCHEMBL8019441 | 0.82 | HSD17B10 (0.34) | HSD17B10CYP2D6CYP2C19POLBCYP2C9 | |
| SCHEMBL7139127 | 0.82 | CYP2D6 (0.37) | CYP2D6CYP2C19POLBCYP2C9KMT2A | |
| SCHEMBL30875935 | 0.82 | ITGB3 (0.43) | CYP2D6CYP2C19POLBCYP2C9KMT2A | |
| SCHEMBL3489028 | 0.80 | S1PR1 (0.41) | HSD17B10POLBTSHR | |
| SCHEMBL23291471 | 0.79 | KMT2A (0.63) | CYP2D6CYP2C19POLBCYP2C9KMT2A | |
| SCHEMBL23291436 | 0.79 | CYP2D6 (0.63) | CYP2D6CYP2C19POLBCYP2C9KMT2A | |
| SCHEMBL30875934 | 0.77 | PTGS1 (0.41) | CYP2D6CYP2C19POLBCYP2C9KMT2A | |
| SCHEMBL30875932 | 0.77 | PTGS1 (0.41) | CYP2D6CYP2C19POLBCYP2C9KMT2A | |
| SCHEMBL2544936 | 0.77 | PIK3CD (0.55) | HSD17B10POLBKMT2ASLC6A9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2249967-B1 | OXIDIZED AND MALEATED DERIVATIVE COMPOSITION | INGEVITY SOUTH CAROLINA LLC (US) | 2019-03-13 | — | — | EP | disclosed |
| US-8133970-B2 | Oxidized and maleated derivative compositions | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2012-03-13 | — | — | US | disclosed |
| EP-2170277-A1 | CHEMICAL MODIFICATION OF MALEATED FATTY ACIDS | Georgia-Pacific Chemicals LLC (US) | 2010-04-07 | — | — | EP | disclosed |
| US-20090194731-A1 | OXIDIZED AND MALEATED DERIVATIVE COMPOSITIONS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-08-06 | — | — | US | disclosed |
| US-20090065736-A1 | CHEMICAL MODIFICATION OF MALEATED FATTY ACIDS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-03-12 | — | — | US | disclosed |
| WO-2009006527-A1 | CHEMICAL MODIFICATION OF MALEATED FATTY ACIDS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090194731-A1 | OXIDIZED AND MALEATED DERIVATIVE COMPOSITIONS | FASN, TKFC, ELOVL5 | HSD17B10 672/4885CYP2D6 888/4885CYP2C19 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.